American Association for Cancer Research
Browse
15357163mct080156-sup-mct-08-0156--suppl_fig_1.pdf (193.21 kB)

Supplementary Fig. S1 from Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites

Download (193.21 kB)
journal contribution
posted on 2023-03-31, 23:29 authored by Stéphane Honoré, Alessandra Pagano, Géraldine Gauthier, Véronique Bourgarel-Rey, Pascal Verdier-Pinard, Karine Civiletti, Anna Kruczynski, Diane Braguer
Supplementary Fig. S1 from Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites

History

ARTICLE ABSTRACT

The motile behavior of endothelial cells is a crucial event for neoangiogenesis. We previously showed that noncytotoxic concentrations of vinflunine inhibit capillary-like tube formation on Matrigel and endothelial cell migration with a concomitant increase in interphase microtubule dynamic instability. In this article, we further investigated the effects of vinflunine on migration and cytoskeleton interaction dynamics in HMEC-1 endothelial cells. We confirmed that vinflunine, at low and noncytotoxic concentrations (0.01–1 nmol/L), inhibited endothelial cell random motility by 54%. This effect was associated with a decrease in the percentage of stable microtubules and in the mean duration of pauses for dynamic ones. Moreover, we found that vinflunine altered adhesion site targeting by microtubules and suppressed the microtubule (+) end pause that occurs at adhesion sites during cell migration (from 151 ± 20 seconds in control cells to 38 ± 7 seconds in vinflunine-treated cells, P < 0.001). This effect was associated with the inhibition of adhesion site dynamics and the formation of long-lived stress fibers. Importantly, we found that vinflunine altered EB1 localization at microtubule (+) ends. These results highlight a new mechanism of action of vinflunine, which act by disrupting the mutual control between microtubule and adhesion site dynamics and strengthen the role of +TIPs proteins such as EB1 as key regulators of endothelial cell motility. [Mol Cancer Ther 2008;7(7):2080–9]

Usage metrics

    Molecular Cancer Therapeutics

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC